Industry benchmark · SIC 72110
Research and experimental development on biotechnology
6,106 active companies are registered under this code; 34 publish a P&L we can benchmark.
Benchmarks
- Median revenue
- £5.1m
- Median profit
- −£4.6k
- Profitable
- 44%
- Median staff
- 46
- Median margin
- −0.7%
- Top-quartile margin
- 6.9%
- Median gross margin
- 45.3%
- Median profit / staff
- −£5.2k
Median
−0.7%
Top quartile (p75)
6.9%
Median revenue growth: ▲8.9%
Ranked by profit
Top research and experimental development on biotechnology businesses
| # | Company | Revenue | Profit | Margin | Staff |
|---|---|---|---|---|---|
| 1 | Astex Therapeutics Limited Cambridge · Research and experimental development on biotechnology Operating leverage | £404m | £283m | 70.2% | 183 |
| 2 | Charles River U.K. Limited Kent · Research and experimental development on biotechnology | £22.2m | £18.8m | 84.9% | 129 |
| 3 | Qiagen Manchester Limited Manchester · Research and experimental development on biotechnology Operating leverageDoing more with less | £53.7m | £11.8m | 21.9% | 239 |
| 4 | Theradex (Europe) Limited Redhill · Research and experimental development on biotechnology IndependentCapital-light+2 | £15.2m | £3.1m | 20.3% | 43 |
| 5 | Novogene (UK) Company Limited Cambridge · Research and experimental development on biotechnology Capital-lightOperating leverage+2 | £38.2m | £2.8m | 7.3% | 68 |
| 6 | Askbio UK Ltd Midlothian · Research and experimental development on biotechnology | £12.5m | £1.8m | 14.2% | 54 |
| 7 | Origio Limited Fareham · Research and experimental development on biotechnology Capital-lightOperating leverage | £20.1m | £499k | 2.5% | 82 |
| 8 | Flatiron Health UK Ltd ST Albans · Research and experimental development on biotechnology Capital-lightOperating leverage | £9.5m | £239k | 2.5% | 32 |
| 9 | Adorx Therapeutics Limited Edinburgh · Research and experimental development on biotechnology Small teamCash flow filed | £1.2m | £211k | 17.6% | 0 |
| 10 | Biopharma Process Systems Limited Winchester · Research and experimental development on biotechnology Cash flow filed | £10.1m | £142k | 1.4% | 66 |
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.